Related Experiment Videos
Mdm2 inhibits the apoptotic function of p53 mainly by targeting it for degradation
1Ludwig Institute for Cancer Research, Imperial College of Science, Technology and Medicine at St. Mary's Campus, Norfolk Place, London, W2 1PG United Kingdom.
Abstract:
The ability of Mdm2 to inhibit the activities of a C-terminal truncated p53 mutant, p53-Delta30, which can bind Mdm2 but is resistant to Mdm2-mediated protein degradation was investigated. The inhibitory function of an Mdm2 mutant, Mdm2-Delta(222-437), which can bind p53 but is defective in targeting p53 for degradation was also studied. We have demonstrated that targeting p53 for degradation is the most effective way for Mdm2 to inhibit the apoptotic function of p53. However, we have also shown that Mdm2 can inhibit the transactivation function of p53 without targeting it for degradation, although Mdm2 releases the transrepression ability of p53 mainly by targeting it for degradation. The ability of Mdm2 to inhibit the apoptotic function of p53 was linked to its ability to inhibit the transrepression but not the transactivation function of p53. Furthermore, we have demonstrated that the transrepression function of p53 was specific to p53-induced apoptosis and was not simply a result of cell death.
Insights
Mdm2 inhibits p53
Area of Science:
- Molecular Biology
- Cancer Research
Background:
- Mdm2 is a key regulator of the tumor suppressor p53.
- Mdm2's functions include inhibiting p53 activity and targeting it for degradation.
- The precise mechanisms by which Mdm2 inhibits p53's diverse functions are not fully understood.
Purpose of the Study:
- To investigate how Mdm2 inhibits the apoptotic and transactivation/transrepression functions of p53.
- To determine the role of p53 degradation in Mdm2-mediated inhibition.
- To analyze the specific contribution of p53's transrepression function to apoptosis.
Main Methods:
- Utilized C-terminal truncated p53 mutants (p53-Delta30) resistant to degradation.
- Employed an Mdm2 mutant (Mdm2-Delta(222-437)) defective in targeting p53 for degradation.
- Assessed Mdm2's effects on p53's transactivation, transrepression, and apoptotic functions.
Main Results:
- Mdm2 most effectively inhibits p53's apoptotic function by targeting it for degradation.
- Mdm2 can inhibit p53's transactivation function independently of degradation.
- Mdm2 releases p53's transrepression ability primarily through degradation.
- Inhibition of p53's transrepression function, not transactivation, correlates with Mdm2's inhibition of p53-induced apoptosis.
- p53's transrepression function is specific to p53-induced apoptosis.
Conclusions:
- p53 degradation is the primary mechanism for Mdm2 to inhibit p53-induced apoptosis.
- Mdm2 employs distinct mechanisms to inhibit p53's transactivation and transrepression functions.
- Understanding these differential inhibition mechanisms provides insight into p53 regulation in cancer.